ConductScience.org, home

Paper35359702

Can anti-parasitic drugs help control COVID-19?

Panahi Y and 7 others. Future Virol, 2022. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Can anti-parasitic drugs help control COVID-19? Papers, record 35359702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35359702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Can anti-parasitic drugs help control COVID-19?
PubMed
Journal
Future Virol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2022-04-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References194

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125108173Nitazoxanide: a first-in-class broad-spectrum antiviral agent.Antiviral Res2014https://conductscience.org/library/papers/25108173PubMed
217314215
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Rheumatology (Oxford)2007https://conductscience.org/library/papers/17314215PubMed
332378705A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity.Biosci Rep2020https://conductscience.org/library/papers/32378705PubMed
432075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
531320117Advancing Drug Discovery via Artificial Intelligence.Trends Pharmacol Sci2019https://conductscience.org/library/papers/31320117PubMed
632735799Roles of flavonoids against coronavirus infection.Chem Biol Interact2020https://conductscience.org/library/papers/32735799PubMed
716122816Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.Antiviral Res2005https://conductscience.org/library/papers/16122816PubMed
832275497Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020.Emerg Infect Dis2020https://conductscience.org/library/papers/32275497PubMed
932271460Coronavirus disease 2019: a bibliometric analysis and review.Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/32271460PubMed
1033264556Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.N Engl J Med2021https://conductscience.org/library/papers/33264556PubMed
1132409561Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.BMJ2020https://conductscience.org/library/papers/32409561PubMed
1232125140Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.ACS Infect Dis2020https://conductscience.org/library/papers/32125140PubMed
1332247927Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.Travel Med Infect Dis2020https://conductscience.org/library/papers/32247927PubMed
1433300221Repurposing of some anti-infective drugs for COVID-19 treatment: A surveillance study supported by an in silico investigation.Int J Clin Pract2021https://conductscience.org/library/papers/33300221PubMed
1533815126Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug.Front Pharmacol2021https://conductscience.org/library/papers/33815126PubMed
1633170521Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach.Drug Dev Res2021https://conductscience.org/library/papers/33170521PubMed
1733590901Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.J Med Virol2021https://conductscience.org/library/papers/33590901PubMed
1832407884QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.Heart Rhythm2020https://conductscience.org/library/papers/32407884PubMed
1925730813Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus.Pak J Pharm Sci2015https://conductscience.org/library/papers/25730813PubMed
2011727315Computational methods to estimate drug development parameters.Curr Opin Drug Discov Devel2001https://conductscience.org/library/papers/11727315PubMed

See all 194 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
38980578Exploring COVID-19 Pandemic Disparities with Transcriptomic Meta-analysis from the Perspective of Personalized Medicine.J Microbiol2024https://conductscience.org/library/papers/38980578PubMed
37375747Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37375747PubMed
36915278A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?Future Virol2023https://conductscience.org/library/papers/36915278PubMed
36116513Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.Chem Biol Interact2022https://conductscience.org/library/papers/36116513PubMed
35744958Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?Molecules2022https://conductscience.org/library/papers/35744958PubMed

Download CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
ANO155107PubTator's text mininghttps://conductscience.org/library/genes/55107NCBI Gene
BSG682PubTator's text mininghttps://conductscience.org/library/genes/682NCBI Gene
CCL46351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CGAS115004PubTator's text mininghttps://conductscience.org/library/genes/115004NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene
ERVK-664006PubTator's text mininghttps://conductscience.org/library/genes/64006NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
IFIH164135PubTator's text mininghttps://conductscience.org/library/genes/64135NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
IMPA13612PubTator's text mininghttps://conductscience.org/library/genes/3612NCBI Gene
MAVS57506PubTator's text mininghttps://conductscience.org/library/genes/57506NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
NPC14864PubTator's text mininghttps://conductscience.org/library/genes/4864NCBI Gene
ROBO364221PubTator's text mininghttps://conductscience.org/library/genes/64221NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35359702

GET https://conductscience.org/api/papers/v1/35359702/references?page=2